Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc., a leading biopharmaceutical company headquartered in the United States, focuses on innovative solutions for pain management and surgical care. Founded in 2006, Pacira has made significant strides in the industry, particularly with its flagship product, EXPAREL, a long-acting local anaesthetic that enhances postoperative pain control while reducing the need for opioids. With a commitment to advancing patient care, Pacira operates primarily in North America and has expanded its reach into various surgical specialties. The company is recognised for its unique approach to pain management, positioning itself as a pioneer in the development of non-opioid therapies. Notable achievements include a strong market presence and partnerships that further its mission to improve surgical outcomes and patient recovery.
DitchCarbon Score
How does Pacira Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pacira Pharmaceuticals, Inc.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pacira Pharmaceuticals, Inc.'s reported carbon emissions
Pacira Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As of now, there are no documented initiatives or commitments related to carbon emissions reduction or climate pledges. In the absence of specific emissions figures, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This trend often includes setting science-based targets and committing to reducing greenhouse gas emissions across various scopes. However, without concrete data or commitments from Pacira Pharmaceuticals, it is unclear how they are addressing climate change and carbon emissions within their operations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pacira Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
